| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.2B | — | — | — | — | $1.8B | $1.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.0B | $0.8B | $0.9B | $0.9B | $1.0B | $0.8B | $0.4B | $0.5B |
| EPS (Basic) | $1.89 | $1.37 | $1.58 | $1.62 | $1.76 | $1.90 | $1.39 | $1.66 |
| EPS (Diluted) | $1.87 | $1.36 | $1.54 | $1.53 | $1.74 | $1.89 | $1.38 | $1.65 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $83.9B | $82.2B | $81.7B | $79.0B | $89.1B | $84.2B | $43.3B | $40.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $74.7B | $73.0B | $72.4B | $70.4B | $80.6B | $75.9B | $38.2B | $36.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $8.8B | $8.8B | $9.0B | $8.3B | $8.2B | $8.0B | $4.8B | $4.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $1.3B | $1.3B | $2.3B | $0.7B | $0.2B | $0.8B | $0.2B |
| Investing Cash Flow | $-1.1B | $-1.1B | $-2.6B | $8.3B | $-4.6B | $-5.0B | $-2.4B | $0.5B |
| Capital Expenditures | $0.0B | $0.0B | — | — | — | — | — | — |
| Financing Cash Flow | $0.5B | $-0.4B | $1.5B | $-10.9B | $4.0B | $5.2B | $1.4B | $-0.8B |